Amyris closes upsized offering of $690.0 million of 1.50% convertible senior notes due 2026

Emeryville, calif., nov. 15, 2021 /prnewswire/ -- amyris, inc. (nasdaq: amrs), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its lab-to-markettm operating platform, announced that it has closed its offering of 1.50% convertible senior notes due 2026 (the "notes"), for gross proceeds of $690.0 million.

AMRS Ratings Summary

AMRS Quant Ranking